Mako Surgical (UNKNOWN:MAKO.DL) has been one of the most controversial stocks in the medical device space over the last two years. Shares have plunged more than 50% over this time span, and the company hasn't been able to become profitable. Today, however, some shareholders may be smiling at the company's reversal of fortune.

In a surprising move that caught many investors by surprise, medical device specialist Stryker (NYSE:SYK) announced that it will acquire Mako for a hefty $1.65 billion. Health care analyst Max Macaluso has details on this deal in the following video.

Max Macaluso, Ph.D., has no position in any stocks mentioned. The Motley Fool recommends Mako Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.